Dyadic International (DYAI) - Wutah bathi ing taun lumaku

Lambang korporat lan logo Dyadic International (DYAI)

The non-cyclical nature of biotechnology provides Dyadic International (DYAI) with macro-resilience, as confirmed by the comparison of annual EPS growth. The value 38.80 determines this parameter level, reflecting the company's high reputation due to its unique protein synthesis. Consequently, the licensing of the C1 platform creates a stable effect which, combined with long-term drug commercialization, is fully priced into current quotes.

DYAI Wutah bathi ing taun lumaku Dyadic International (04.07.2022 - 11.11.2026)

Rincian metrik keuangan lan pasar dyadic.com (DYAI)

- rega saham lan target rega konsensus:
Bagan owah-owahan rega Dyadic International, Inc.|DYAI - Target konsensus
- indikator kapitalisasi pasar:
Kapitalisasi pasar DYAI|DYAI - Nilai Total Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Saham Dyadic International|DYAI - Kapitalisasi Buku|Rasio Kapitalisasi marang Nilai Buku dyadic.com|DYAI - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Dyadic International|DYAI - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Dyadic International, Inc.|DYAI - Gunggung utang perusahaan|Rasio utang marang nilai buku DYAI|DYAI - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Dyadic International|Indikator likuiditas cepet dyadic.com
- data bathi lan kelipatan valuasi:
DYAI - Penghasilan resik|Penghasilan resik sing dikarepake Dyadic International|DYAI - Pangali P/E|Kapitalisasi marang proyeksi bathi Dyadic International, Inc.|DYAI - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan DYAI|DYAI - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Dyadic International|DYAI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan dyadic.com|DYAI - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Dyadic International
Pambiji fundamental:Dyadic
Produk mawa merek dyadic.com

The long-term sustainability of Dyadic International (DYAI) is determined by its ability to consistently increase net income per share. This metric measures the annual growth rate of EPS, reflecting cost management efficiency and real profit growth. By analyzing the change in EPS compared to the previous year, an investor assesses the business scaling dynamics. For Dyadic International (DYAI), this indicator confirms the profitability of the C1 system's licensing model. High-margin royalties ensure steady profit growth with minimal capital expenditures.

Pesaing langsung

Gilead - Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki CDTX|Wutah bathi ing taun lumaku Novavax Pharma|Wutah bathi saben saham ing taun lumaku CureVac N.V. (CVAC)|Prakiraan wutah bathi resik saben saham ing taun iki valneva.com|Wutah bathi ing taun lumaku VIR (Vir Biotechnology)|SIGA: Wutah bathi saben saham ing taun iki|EBS: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku Atea Corp|IVVD: Wutah bathi ing taun lumaku|enanta.com (ENTA) - Wutah bathi ing taun lumaku|INO (Inovio) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki HLVX (HilleVax Inc)|Wutah bathi ing taun lumaku KLRS|Prakiraan wutah bathi resik saben saham ing taun iki nanoviricides.com|Wutah bathi ing taun lumaku TLPH (Talphera, Inc.)|COCP - Wutah bathi resik saben saham ing taun iki|TRAW: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku DWTX (Dogwood Therapeutics, Inc.)|QLGN: Wutah bathi ing taun lumaku|ALVR - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku VBI Vaccines, Inc.|Wutah bathi saben saham ing taun iki VIRI (Virios)|Wutah bathi resik saben saham ing taun iki VXRT (Vaxart, Inc.)